January 17, 2025
[NVO, BHC, TEVA] Quantifying IRA Price Negotiation Risks
Our analysis of the drugs included in the CY27 cycle of price negotiations under the Inflation Reduction Act (IRA) announced this morning implies a 3%-4% headwind for NVO relative to consensus CY27 revenues, with a…